Bovine Mastitis Market

1. Bovine Mastitis Market to Experience Significant Growth during the Forecast Period 2022-2030 The global bovine mastitis market size was valued at USD 540 million in 2021 and is projected to reach around USD 1,100 million in 2030 exhibiting a CAGR of 6.5% in the forecasted period. The increasing incidence of bovine mastitis, growing products approval and launches by market players are anticipated to upsurge the market growth. Moreover, rising prevalence of bovine mastitis infections during the dry season, as well as the increased benefits of non-antibiotic intramammary products are projected to boost the market. However, increased antibiotic resistance and lack of awareness about the diseases are the factors hindering the growth of the market in the forecasted period. Request https://wemarketresearch.com/reports/request-free-sample-pdf/bovine-mastitis- market/859 Free Sample Copy of this Report@ The growth in the prevalence of bovine mastitis and the increase in the incidence of cow injury boost the growth of the bovine mastitis market. For instance, as per the research article published on August 2020, in Veterinary Medicine International, an editor of original research articles and review articles in all parts of veterinary research, the complete prevalence of mastitis described was 80% in Kenya. Bovine mastitis is mostly affected by numerous bacterial & fungal infections such as Str. agalactiae, Staphylococcus aureus, Str. zooepidemicus, Str. Pyogenes, Str. faecalis, Pasteurella multocida, and Aspergillus fumigatus. Additionally, the growth in the number of dairy farms and boost in the construction of dairy products furl the growth of the bovine mastitis market. The upsurge in demand for dairy products and an increase in milk production fuel the growth of the bovine mastitis industry. For example, as per the United States Department of Agriculture (USDA’s) Milk Production

2. article, the yearly milk production in the U.S. in 2020 was 223 billion pounds, growing just over 2% from the 218 billion pounds manufactured in 2019. The COVID-19 outbreak is expected to have a negative impact on the growth of the bovine mastitis market as there is lockdown in many nations. The COVID-19 pandemic affected the supply chain for farmhouses and dairy industry. The complete healthcare industry has dedicated on life saving and COVID-19 associated products throughout the pandemic which confine the treatment of bovine mastitis. Thus, COVID-19 had substantial negative impact on bovine mastitis market. Though, the healthcare sector has been reorganized to offer harmless healthcare facilities. Later, the market is predicted to grow in post pandemic situations. The market for bovine mastitis is moderately competitive. With the rising applications of bovine mastitis, new players are considering to enter the market. The companies are also involved in activities like joint ventures, acquisitions, partnerships, mergers, and collaborations. These activities aid in growing the effect of the players in the bovine mastitis market, ultimately boosting the market growth. Secure https://wemarketresearch.com/purchase/bovine-mastitis-market/859?license=single A Copy Of The Premium Research Report@ Competitive Analysis Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, Nimrod Veterinary Products Ltd. About We Market Research: WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep-rooted market studies and insightful analysis of different markets. Contact Us: We Market Research Phone: +1(650)-666-4592 Email: sales@wemarketresearch.com Web: https://wemarketresearch.com/